Nedaplatin- versus cisplatin-based chemotherapy in the survival time of patients with non-small cell lung cancer

Nedaplatin (NDP) has been extensively used to treat patients with non-small cell lung cancer (NSCLC) in the last decade. The present study compared the survival benefits of NDP and cisplatin (DDP) in the treatment of NSCLC. Patients (n=392) with NSCLC were treated with at least two cycles of platinu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: SHAN, JINLU, XIONG, YANLI, WANG, DONG, XU, MINGFANG, YANG, YI, GONG, KAN, YANG, ZHENZHOU, WANG, GE, YANG, XUEQIN
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4471614/
https://ncbi.nlm.nih.gov/pubmed/26137264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.504
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados